Here is another question related to stem cell-based therapies.
Q: How long will it take for stem cell-based therapies to become mainstream?
A: There are multiple ongoing clinical trials based on stem cell-based therapies. I feel that the development of workflows for manufacturing and quality control is one of the key issues. Regulators (such as FDA), researchers, clinicians, and manufactures should work together to solve this issue.
Thank you for reading this blog. Enjoy wonderful Sunday. Fondly, Fumi Urano
